Clinical and biological significance of RNA N6-methyladenosine regulators in Alzheimer disease.

Qiu, Zhiqiang; Bai, Xuanyang; Han, Xinye; Wang, Peishen; Wang, Xiang; Lv, Yuxia; An, Yihua

Qiu, Zhiqiang; Bai, Xuanyang; Han, Xinye; Wang, Peishen; Wang, Xiang; Lv, Yuxia; An, Yihua.

Afiliação

Qiu Z; Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China.
Bai X; School of Public Health, China Medical University, Shenyang, Liaoning Province, China.
Han X; Department of Research and Development, Beijing Yihua Biotechnology Co., Ltd, Beijing, China.
Wang P; Department of Research and Development, Beijing Yihua Biotechnology Co., Ltd, Beijing, China.
Wang X; Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China.
Lv Y; Medical Supply Center of Chinese PLA General Hospital, Beijing, China.
An Y; Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China.

Medicine (Baltimore) ; 102(7): e32945, 2023 Feb 17.

Article em En | MEDLINE | ID: mdl-36800593

Assuntos

Doença de Alzheimer; Humanos; Doença de Alzheimer/genética; Adenosina; Bases de Dados Factuais; RNA

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Medicine (Baltimore) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google